uploads/2018/05/eps-estimate-1.png

Analysts Expect a Fall in Dentsply Sirona’s Adjusted Earnings

By

Updated

Dentsply Sirona’s 1Q18 earnings

Dentsply Sirona (XRAY) accounts for ~0.29% of the total holdings of the Vanguard Mid-Cap ETF (VO). The company is set to release its 1Q18 results on May 7. 

The company has recently made some key management changes and put in place a robust turnaround plan after taking on significant impairment charges in 2017 due to lower-than-expected synergies from the merger of Dentsply International and Sirona Dental Systems in February 2016. In this article, we’ll discuss what’s expected of the company’s 1Q18 earnings.

Article continues below advertisement

Analysts’ 1Q18 earnings estimates

According to analysts’ estimates, Dentsply Sirona’s 1Q18 adjusted diluted EPS (earnings per share) will come in at ~$0.42. The company posted adjusted diluted EPS of $0.49 in 1Q17 and $0.82 in 4Q17.

On April 16, Jefferies provided an update on its 1Q18 earnings estimate for Dentsply Sirona. The investment research company also reiterated its “buy” rating on the stock while cutting its target price for the stock. As per Jefferies, Dentsply Sirona will register adjusted EPS of $0.43 in 1Q18 compared to its previous estimate of $0.47.

Dentsply Sirona expects its 1Q18 earnings to remain under pressure due to the various efficiency improvements and cost-containment strategic initiatives it’s undertaken as part of its recent turnaround plan.

Dentsply Sirona’s peers Zimmer Biomet Holdings (ZBH), Align Technology (ALGN), and Integra LifeSciences Holdings (IART) reported adjusted EPS of $1.91, $1.17, and $0.58, respectively, in their recently ended quarters.

In the next article, we’ll take a look at Dentsply Sirona’s 1Q18 sales expectations.

Advertisement

More From Market Realist